LymphedemaV1, PascalFrancis, Corpus, bibRecord, 000B97

Treatment of secondary lymphedema of the upper limb with cyclo 3 fort

Identifieur interne : 000B97 ( PascalFrancis/Corpus ); précédent : 000B96; suivant : 000B98

Treatment of secondary lymphedema of the upper limb with cyclo 3 fort

Auteurs : R. V. Cluzan ; F. Alliot ; S. Ghabboun ; M. Pascot

Source :

Lymphology [ 0024-7766 ] ; 1996.

RBID : Pascal:96-0216041

Descripteurs français

Pascal (Inist)
- Lymphoedème, Membre supérieur, Secondaire, Hespéridine, Chimiothérapie, Traitement, Exploration, Homme, Etude comparative, Flavonoïde, Veinotrope.

English descriptors

KwdEn :
- Chemotherapy, Comparative study, Exploration, Flavonoid, Hesperidin, Human, Lymphedema, Secondary, Treatment, Upper limb, Venotropic agent.

Abstract

Fifty seven patients with secondary lymphedema of the upper limb after previous treatment for breast cancer were treated for 3 months with an extract of Ruscus + Hesperidin Methyl Chalcone (CYCLO 3 FORT) or placebo according to a double-blind protocol in the context of a controlled clinical trial. All patients also underwent manual lymphatic drainage twice a week for at least one month. With CYCLO 3 FORT, the reduction in volume of arm edema, the main assessment criteria, was 12.9% after 3 months of treatment as compared with a placebo (p=0.009). Decreased edema tended to be more marked in the forearm compared with the upper arm where excess fat deposition seemed to dominate over excess fluid accumulation. CYCLO 3 FORT was well tolerated with minimal adverse reaction.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0024-7766`
A02	`01`			`@0 LYMPBN`
A03		`1`		`@0 Lymphology`
A05				`@2 29`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Treatment of secondary lymphedema of the upper limb with cyclo 3 fort`
A11	`01`	`1`		`@1 CLUZAN (R. V.)`
A11	`02`	`1`		`@1 ALLIOT (F.)`
A11	`03`	`1`		`@1 GHABBOUN (S.)`
A11	`04`	`1`		`@1 PASCOT (M.)`
A14	`01`			`@1 Unité de Lymphologie, Hôpital Cognacq-Jay @2 Paris @3 FRA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut.`
A20				`@1 29-35`
A21				`@1 1996`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 14604 @5 354000044471330060`
A44				`@0 0000`
A45				`@0 11 ref.`
A47	`01`	`1`		`@0 96-0216041`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Lymphology`
A66	`01`			`@0 INT`
C01	`01`		`ENG`	@0 Fifty seven patients with secondary lymphedema of the upper limb after previous treatment for breast cancer were treated for 3 months with an extract of Ruscus + Hesperidin Methyl Chalcone (CYCLO 3 FORT) or placebo according to a double-blind protocol in the context of a controlled clinical trial. All patients also underwent manual lymphatic drainage twice a week for at least one month. With CYCLO 3 FORT, the reduction in volume of arm edema, the main assessment criteria, was 12.9% after 3 months of treatment as compared with a placebo (p=0.009). Decreased edema tended to be more marked in the forearm compared with the upper arm where excess fat deposition seemed to dominate over excess fluid accumulation. CYCLO 3 FORT was well tolerated with minimal adverse reaction.
C02	`01`	`X`		`@0 002B02F08`
C03	`01`	`X`	`FRE`	`@0 Lymphoedème @5 01`
C03	`01`	`X`	`ENG`	`@0 Lymphedema @5 01`
C03	`01`	`X`	`SPA`	`@0 Linfedema @5 01`
C03	`02`	`X`	`FRE`	`@0 Membre supérieur @5 02`
C03	`02`	`X`	`ENG`	`@0 Upper limb @5 02`
C03	`02`	`X`	`SPA`	`@0 Miembro superior @5 02`
C03	`03`	`X`	`FRE`	`@0 Secondaire @5 03`
C03	`03`	`X`	`ENG`	`@0 Secondary @5 03`
C03	`03`	`X`	`SPA`	`@0 Secundario @5 03`
C03	`04`	`X`	`FRE`	`@0 Hespéridine @2 NK @2 FR @5 04`
C03	`04`	`X`	`ENG`	`@0 Hesperidin @2 NK @2 FR @5 04`
C03	`05`	`X`	`FRE`	`@0 Chimiothérapie @5 16`
C03	`05`	`X`	`ENG`	`@0 Chemotherapy @5 16`
C03	`05`	`X`	`SPA`	`@0 Quimioterapia @5 16`
C03	`06`	`X`	`FRE`	`@0 Traitement @5 17`
C03	`06`	`X`	`ENG`	`@0 Treatment @5 17`
C03	`06`	`X`	`GER`	`@0 Aufbereiten @5 17`
C03	`06`	`X`	`SPA`	`@0 Tratamiento @5 17`
C03	`07`	`X`	`FRE`	`@0 Exploration @5 18`
C03	`07`	`X`	`ENG`	`@0 Exploration @5 18`
C03	`07`	`X`	`SPA`	`@0 Exploración @5 18`
C03	`08`	`X`	`FRE`	`@0 Homme @5 20`
C03	`08`	`X`	`ENG`	`@0 Human @5 20`
C03	`08`	`X`	`SPA`	`@0 Hombre @5 20`
C03	`09`	`X`	`FRE`	`@0 Etude comparative @5 23`
C03	`09`	`X`	`ENG`	`@0 Comparative study @5 23`
C03	`09`	`X`	`GER`	`@0 Vergleich @5 23`
C03	`09`	`X`	`SPA`	`@0 Estudio comparativo @5 23`
C03	`10`	`X`	`FRE`	`@0 Flavonoïde @5 27`
C03	`10`	`X`	`ENG`	`@0 Flavonoid @5 27`
C03	`10`	`X`	`SPA`	`@0 Flavonoide @5 27`
C03	`11`	`X`	`FRE`	`@0 Veinotrope @5 28`
C03	`11`	`X`	`ENG`	`@0 Venotropic agent @5 28`
C03	`11`	`X`	`SPA`	`@0 Venotrópico agente @5 28`
C07	`01`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cardiovascular disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Lymphatique pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Linfático patología @5 38`
N21				`@1 148`

Format Inist (serveur)

NO :	PASCAL 96-0216041 INIST
ET :	Treatment of secondary lymphedema of the upper limb with cyclo 3 fort
AU :	CLUZAN (R. V.); ALLIOT (F.); GHABBOUN (S.); PASCOT (M.)
AF :	Unité de Lymphologie, Hôpital Cognacq-Jay/Paris/France (1 aut., 2 aut., 3 aut., 4 aut.)
DT :	Publication en série; Niveau analytique
SO :	Lymphology; ISSN 0024-7766; Coden LYMPBN; International; Da. 1996; Vol. 29; No. 1; Pp. 29-35; Bibl. 11 ref.
LA :	Anglais
EA :	Fifty seven patients with secondary lymphedema of the upper limb after previous treatment for breast cancer were treated for 3 months with an extract of Ruscus + Hesperidin Methyl Chalcone (CYCLO 3 FORT) or placebo according to a double-blind protocol in the context of a controlled clinical trial. All patients also underwent manual lymphatic drainage twice a week for at least one month. With CYCLO 3 FORT, the reduction in volume of arm edema, the main assessment criteria, was 12.9% after 3 months of treatment as compared with a placebo (p=0.009). Decreased edema tended to be more marked in the forearm compared with the upper arm where excess fat deposition seemed to dominate over excess fluid accumulation. CYCLO 3 FORT was well tolerated with minimal adverse reaction.
CC :	002B02F08
FD :	Lymphoedème; Membre supérieur; Secondaire; Hespéridine; Chimiothérapie; Traitement; Exploration; Homme; Etude comparative; Flavonoïde; Veinotrope
FG :	Appareil circulatoire pathologie; Lymphatique pathologie
ED :	Lymphedema; Upper limb; Secondary; Hesperidin; Chemotherapy; Treatment; Exploration; Human; Comparative study; Flavonoid; Venotropic agent
EG :	Cardiovascular disease; Lymphatic vessel disease
GD :	Aufbereiten; Vergleich
SD :	Linfedema; Miembro superior; Secundario; Quimioterapia; Tratamiento; Exploración; Hombre; Estudio comparativo; Flavonoide; Venotrópico agente
LO :	INIST-14604.354000044471330060
ID :	96-0216041

Links to Exploration step

Pascal:96-0216041

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Treatment of secondary lymphedema of the upper limb with cyclo 3 fort</title>
<author><name sortKey="Cluzan, R V" sort="Cluzan, R V" uniqKey="Cluzan R" first="R. V." last="Cluzan">R. V. Cluzan</name>
<affiliation><inist:fA14 i1="01"><s1>Unité de Lymphologie, Hôpital Cognacq-Jay</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Alliot, F" sort="Alliot, F" uniqKey="Alliot F" first="F." last="Alliot">F. Alliot</name>
<affiliation><inist:fA14 i1="01"><s1>Unité de Lymphologie, Hôpital Cognacq-Jay</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ghabboun, S" sort="Ghabboun, S" uniqKey="Ghabboun S" first="S." last="Ghabboun">S. Ghabboun</name>
<affiliation><inist:fA14 i1="01"><s1>Unité de Lymphologie, Hôpital Cognacq-Jay</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pascot, M" sort="Pascot, M" uniqKey="Pascot M" first="M." last="Pascot">M. Pascot</name>
<affiliation><inist:fA14 i1="01"><s1>Unité de Lymphologie, Hôpital Cognacq-Jay</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">96-0216041</idno>
<date when="1996">1996</date>
<idno type="stanalyst">PASCAL 96-0216041 INIST</idno>
<idno type="RBID">Pascal:96-0216041</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000B97</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Treatment of secondary lymphedema of the upper limb with cyclo 3 fort</title>
<author><name sortKey="Cluzan, R V" sort="Cluzan, R V" uniqKey="Cluzan R" first="R. V." last="Cluzan">R. V. Cluzan</name>
<affiliation><inist:fA14 i1="01"><s1>Unité de Lymphologie, Hôpital Cognacq-Jay</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Alliot, F" sort="Alliot, F" uniqKey="Alliot F" first="F." last="Alliot">F. Alliot</name>
<affiliation><inist:fA14 i1="01"><s1>Unité de Lymphologie, Hôpital Cognacq-Jay</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Ghabboun, S" sort="Ghabboun, S" uniqKey="Ghabboun S" first="S." last="Ghabboun">S. Ghabboun</name>
<affiliation><inist:fA14 i1="01"><s1>Unité de Lymphologie, Hôpital Cognacq-Jay</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pascot, M" sort="Pascot, M" uniqKey="Pascot M" first="M." last="Pascot">M. Pascot</name>
<affiliation><inist:fA14 i1="01"><s1>Unité de Lymphologie, Hôpital Cognacq-Jay</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Lymphology</title>
<title level="j" type="abbreviated">Lymphology</title>
<idno type="ISSN">0024-7766</idno>
<imprint><date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Lymphology</title>
<title level="j" type="abbreviated">Lymphology</title>
<idno type="ISSN">0024-7766</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chemotherapy</term>
<term>Comparative study</term>
<term>Exploration</term>
<term>Flavonoid</term>
<term>Hesperidin</term>
<term>Human</term>
<term>Lymphedema</term>
<term>Secondary</term>
<term>Treatment</term>
<term>Upper limb</term>
<term>Venotropic agent</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lymphoedème</term>
<term>Membre supérieur</term>
<term>Secondaire</term>
<term>Hespéridine</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Exploration</term>
<term>Homme</term>
<term>Etude comparative</term>
<term>Flavonoïde</term>
<term>Veinotrope</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Fifty seven patients with secondary lymphedema of the upper limb after previous treatment for breast cancer were treated for 3 months with an extract of Ruscus + Hesperidin Methyl Chalcone (CYCLO 3 FORT) or placebo according to a double-blind protocol in the context of a controlled clinical trial. All patients also underwent manual lymphatic drainage twice a week for at least one month. With CYCLO 3 FORT, the reduction in volume of arm edema, the main assessment criteria, was 12.9% after 3 months of treatment as compared with a placebo (p=0.009). Decreased edema tended to be more marked in the forearm compared with the upper arm where excess fat deposition seemed to dominate over excess fluid accumulation. CYCLO 3 FORT was well tolerated with minimal adverse reaction.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0024-7766</s0>
</fA01>
<fA02 i1="01"><s0>LYMPBN</s0>
</fA02>
<fA03 i2="1"><s0>Lymphology</s0>
</fA03>
<fA05><s2>29</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Treatment of secondary lymphedema of the upper limb with cyclo 3 fort</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>CLUZAN (R. V.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>ALLIOT (F.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>GHABBOUN (S.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>PASCOT (M.)</s1>
</fA11>
<fA14 i1="01"><s1>Unité de Lymphologie, Hôpital Cognacq-Jay</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>29-35</s1>
</fA20>
<fA21><s1>1996</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>14604</s2>
<s5>354000044471330060</s5>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>11 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>96-0216041</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Lymphology</s0>
</fA64>
<fA66 i1="01"><s0>INT</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Fifty seven patients with secondary lymphedema of the upper limb after previous treatment for breast cancer were treated for 3 months with an extract of Ruscus + Hesperidin Methyl Chalcone (CYCLO 3 FORT) or placebo according to a double-blind protocol in the context of a controlled clinical trial. All patients also underwent manual lymphatic drainage twice a week for at least one month. With CYCLO 3 FORT, the reduction in volume of arm edema, the main assessment criteria, was 12.9% after 3 months of treatment as compared with a placebo (p=0.009). Decreased edema tended to be more marked in the forearm compared with the upper arm where excess fat deposition seemed to dominate over excess fluid accumulation. CYCLO 3 FORT was well tolerated with minimal adverse reaction.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B02F08</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Membre supérieur</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Upper limb</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Miembro superior</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Secondaire</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Secondary</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Secundario</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Hespéridine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Hesperidin</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Exploration</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Exploration</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Exploración</s0>
<s5>18</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="GER"><s0>Vergleich</s0>
<s5>23</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>23</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Flavonoïde</s0>
<s5>27</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Flavonoid</s0>
<s5>27</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Flavonoide</s0>
<s5>27</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Veinotrope</s0>
<s5>28</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Venotropic agent</s0>
<s5>28</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Venotrópico agente</s0>
<s5>28</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fN21><s1>148</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 96-0216041 INIST</NO>
<ET>Treatment of secondary lymphedema of the upper limb with cyclo 3 fort</ET>
<AU>CLUZAN (R. V.); ALLIOT (F.); GHABBOUN (S.); PASCOT (M.)</AU>
<AF>Unité de Lymphologie, Hôpital Cognacq-Jay/Paris/France (1 aut., 2 aut., 3 aut., 4 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Lymphology; ISSN 0024-7766; Coden LYMPBN; International; Da. 1996; Vol. 29; No. 1; Pp. 29-35; Bibl. 11 ref.</SO>
<LA>Anglais</LA>
<EA>Fifty seven patients with secondary lymphedema of the upper limb after previous treatment for breast cancer were treated for 3 months with an extract of Ruscus + Hesperidin Methyl Chalcone (CYCLO 3 FORT) or placebo according to a double-blind protocol in the context of a controlled clinical trial. All patients also underwent manual lymphatic drainage twice a week for at least one month. With CYCLO 3 FORT, the reduction in volume of arm edema, the main assessment criteria, was 12.9% after 3 months of treatment as compared with a placebo (p=0.009). Decreased edema tended to be more marked in the forearm compared with the upper arm where excess fat deposition seemed to dominate over excess fluid accumulation. CYCLO 3 FORT was well tolerated with minimal adverse reaction.</EA>
<CC>002B02F08</CC>
<FD>Lymphoedème; Membre supérieur; Secondaire; Hespéridine; Chimiothérapie; Traitement; Exploration; Homme; Etude comparative; Flavonoïde; Veinotrope</FD>
<FG>Appareil circulatoire pathologie; Lymphatique pathologie</FG>
<ED>Lymphedema; Upper limb; Secondary; Hesperidin; Chemotherapy; Treatment; Exploration; Human; Comparative study; Flavonoid; Venotropic agent</ED>
<EG>Cardiovascular disease; Lymphatic vessel disease</EG>
<GD>Aufbereiten; Vergleich</GD>
<SD>Linfedema; Miembro superior; Secundario; Quimioterapia; Tratamiento; Exploración; Hombre; Estudio comparativo; Flavonoide; Venotrópico agente</SD>
<LO>INIST-14604.354000044471330060</LO>
<ID>96-0216041</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B97 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000B97 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:96-0216041
   |texte=   Treatment of secondary lymphedema of the upper limb with cyclo 3 fort
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Treatment of secondary lymphedema of the upper limb with cyclo 3 fort

Treatment of secondary lymphedema of the upper limb with cyclo 3 fort

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri